Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus
- PMID: 31439547
- PMCID: PMC6744964
- DOI: 10.1158/0008-5472.CAN-19-1303
Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus
Abstract
Cellular adaptation brought upon by insults such as old age and therapeutic exposure is a complex phenomenon in which cells undergo adaptive phenotypic changes. Our lab has focused on understanding the mechanisms underlying adaptation during the evolution of cancer, from the early stages of development to the ability of cancer cells to escape therapeutic challenges. Our studies span hematopoietic and lung systems. Herein, we discuss the advantages and disadvantages involved in studying two vastly different organ systems. Through the use of these organ/cancer model systems, we hope to develop interventions to limit oncogenic adaptation leading to cancer development and to prevent adaptation of cancers following treatment leading to cancer relapse.
©2019 American Association for Cancer Research.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
References
-
- Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2014 Sub (1973–2012) [Internet].
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous